5-[7-benzyl-5-ethyl-2-methoxy-4-oxo-(7R)-4,5,7,8-tetrahydro-3H-imidazo[2,1-b]purin-3-ylmethyl]-2-methoxybenzonitrile

ID: ALA24228

Chembl Id: CHEMBL24228

PubChem CID: 10205437

Max Phase: Preclinical

Molecular Formula: C26H26N6O3

Molecular Weight: 470.53

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1C(=O)c2c(nc(OC)n2Cc2ccc(OC)c(C#N)c2)N2C[C@@H](Cc3ccccc3)N=C12

Standard InChI:  InChI=1S/C26H26N6O3/c1-4-30-24(33)22-23(32-16-20(28-25(30)32)13-17-8-6-5-7-9-17)29-26(35-3)31(22)15-18-10-11-21(34-2)19(12-18)14-27/h5-12,20H,4,13,15-16H2,1-3H3/t20-/m1/s1

Standard InChI Key:  OKZLZFAEOLBLDC-HXUWFJFHSA-N

Associated Targets(Human)

PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase, PDE1/PDE5 (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 2 and 5 (PDE2 and PDE5) (34 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 3 and 5 (PDE3 and PDE5) (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 4 and 5 (PDE4 and PDE5) (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterases; PDE5 & PDE6 (103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 470.53Molecular Weight (Monoisotopic): 470.2066AlogP: 3.08#Rotatable Bonds: 7
Polar Surface Area: 95.98Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.20CX LogP: 4.21CX LogD: 4.21
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.53Np Likeness Score: -0.69

References

1. Pissarnitski DA, Asberom T, Boyle CD, Chackalamannil S, Chintala M, Clader JW, Greenlee WJ, Hu Y, Kurowski S, Myers J, Palamanda J, Stamford AW, Vemulapalli S, Wang Y, Wang P, Wu P, Xu R..  (2004)  SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction.,  14  (5): [PMID:14980684] [10.1016/j.bmcl.2003.12.027]
2. Antunes JE, Freitas MP, Rittner R..  (2008)  Bioactivities of a series of phosphodiesterase type 5 (PDE-5) inhibitors as modelled by MIA-QSAR.,  43  (8): [PMID:18045743] [10.1016/j.ejmech.2007.10.019]

Source